These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31583612)

  • 1. Evaluating the Relationship Between Lean Liver Volume and Fat-Free Mass.
    Sinha J; Duffull SB; Green B; Al-Sallami HS
    Clin Pharmacokinet; 2020 Apr; 59(4):475-483. PubMed ID: 31583612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is the best size predictor for dose in the obese child?
    Anderson BJ; Holford NH
    Paediatr Anaesth; 2017 Dec; 27(12):1176-1184. PubMed ID: 29076211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating Lean Liver Volume as a Potential Scaler for
    Sinha J; Duffull SB; Green B; Al-Sallami HS
    Curr Drug Metab; 2020; 21(10):746-750. PubMed ID: 32410559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lean body mass as a predictor of drug dosage. Implications for drug therapy.
    Morgan DJ; Bray KM
    Clin Pharmacokinet; 1994 Apr; 26(4):292-307. PubMed ID: 8013162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the best size descriptor to use for pharmacokinetic studies in the obese?
    Green B; Duffull SB
    Br J Clin Pharmacol; 2004 Aug; 58(2):119-33. PubMed ID: 15255794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A standard weight descriptor for dose adjustment in the obese patient.
    Duffull SB; Dooley MJ; Green B; Poole SG; Kirkpatrick CM
    Clin Pharmacokinet; 2004; 43(15):1167-78. PubMed ID: 15568893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of differences in peripheral muscle strength of lean versus obese women: an allometric approach.
    Hulens M; Vansant G; Lysens R; Claessens AL; Muls E; Brumagne S
    Int J Obes Relat Metab Disord; 2001 May; 25(5):676-81. PubMed ID: 11360150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between drug clearance and body size: systematic review and meta-analysis of the literature published from 2000 to 2007.
    McLeay SC; Morrish GA; Kirkpatrick CM; Green B
    Clin Pharmacokinet; 2012 May; 51(5):319-30. PubMed ID: 22439649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lean body mass as a determinant of thyroid size.
    Wesche MF; Wiersinga WM; Smits NJ
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):701-6. PubMed ID: 9713557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexmedetomidine metabolic clearance is not affected by fat mass in obese patients.
    Rolle A; Paredes S; Cortínez LI; Anderson BJ; Quezada N; Solari S; Allende F; Torres J; Cabrera D; Contreras V; Carmona J; Ramírez C; Oliveros AM; Ibacache M
    Br J Anaesth; 2018 May; 120(5):969-977. PubMed ID: 29661414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.
    Kontny NE; Würthwein G; Joachim B; Boddy AV; Krischke M; Fuhr U; Thompson PA; Jörger M; Schellens JH; Hempel G
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):749-63. PubMed ID: 23314734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Considerations for Intravenous Anesthesia Dose in Obese Children: Understanding PKPD.
    Morse JD; Cortinez LI; Anderson BJ
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects.
    Goto T; Onuma T; Takebe K; Kral JG
    Int J Obes Relat Metab Disord; 1995 Dec; 19(12):841-5. PubMed ID: 8963349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic basis of using body size and maturation to predict clearance in humans.
    Anderson BJ; Holford NH
    Drug Metab Pharmacokinet; 2009; 24(1):25-36. PubMed ID: 19252334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fat distribution and end-expiratory lung volume in lean and obese men and women.
    Babb TG; Wyrick BL; DeLorey DS; Chase PJ; Feng MY
    Chest; 2008 Oct; 134(4):704-711. PubMed ID: 18641101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of body composition, fat distribution and sustained weight loss on cardiac function in obesity.
    Kardassis D; Bech-Hanssen O; Schönander M; Sjöström L; Petzold M; Karason K
    Int J Cardiol; 2012 Aug; 159(2):128-33. PubMed ID: 21367473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lean mass, and not fat mass, is an independent determinant of carotid intima media thickness in obese subjects.
    Moreno M; Puig J; Moreno-Navarrete JM; Xifra G; Ortega F; Ricart W; Fernández-Real JM
    Atherosclerosis; 2015 Dec; 243(2):493-8. PubMed ID: 26520905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of anthropometric prediction equations for lean body mass, fat mass and percent fat in adults using the National Health and Nutrition Examination Survey (NHANES) 1999-2006.
    Lee DH; Keum N; Hu FB; Orav EJ; Rimm EB; Sun Q; Willett WC; Giovannucci EL
    Br J Nutr; 2017 Nov; 118(10):858-866. PubMed ID: 29110742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body composition determinants of metabolic phenotypes of obesity in nonobese and obese postmenopausal women.
    Peppa M; Koliaki C; Papaefstathiou A; Garoflos E; Katsilambros N; Raptis SA; Hadjidakis DI; Dimitriadis GD
    Obesity (Silver Spring); 2013 Sep; 21(9):1807-14. PubMed ID: 23696298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal fat, but not lean, mass is increased among overweight/obese women with excess gestational weight gain.
    Berggren EK; Groh-Wargo S; Presley L; Hauguel-de Mouzon S; Catalano PM
    Am J Obstet Gynecol; 2016 Jun; 214(6):745.e1-5. PubMed ID: 26719212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.